Hyaluronic Acid Reversed Wrinkles by 18% in Human Study

The speaker explains that despite the low bioavailability of intact HA, the metabolites produced by gut bacteria appear to be responsible for the skin benefits observed in clinical trials. He reviews multiple RCTs, including a 2021 study showing an 18.8% reduction in wrinkles. The 200 mg dose is the most common in these trials. He personally uses this dose in his own supplement, but he emphasizes that his personal use does not constitute a universal recommendation. The speaker also notes that the benefits are not immediate and likely require consistent, long-term use.

The speaker explains that the initial assumption was that high molecular weight (HMW) hyaluronic acid would be more stable and likely to reach the skin intact. Early studies in rats and dogs used radioactive tags and appeared to show that HMW HA was absorbed whole and distributed to connective tissues. However, a 2023 study using more precise tagging technology revealed that the earlier methods were flawed: the tags may have detached from the HA molecules, leading to false conclusions. The new study showed that HMW HA is first broken down in the stomach into medium-weight pieces, which are then further broken down by gut bacteria into small metabolites. Only these metabolites are absorbed, with a bioavailability of just 2%. The speaker uses the analogy of pulling apart a Lego castle: the long chains are dismantled into individual bricks before the body can use them. This explains why earlier assumptions were wrong and why the benefits of HA supplements must come from these metabolites, not from intact HA reaching the skin.

The speaker reviews several human RCTs. A 2001 trial suggested decreased wrinkle depth. A 2007 study and a 2017 study involving 60 people confirmed these findings. The 2017 study used an objective measure: applying a chemical to make a mold of the skin near the eye, peeling it off, and scanning it to quantify wrinkles. The analysis showed a clear difference between the HA group and placebo. A 2021 RCT of 40 people also showed benefits, though it was funded by Cupqi Corporation, a HA supplier, raising potential bias. However, a 2021 study published in the European Journal of Dermatology found an 18.8% reduction in wrinkles with HA supplements versus a non-significant 2.6% in the placebo group. The most recent 2023 study of 129 people again demonstrated skin benefits. The speaker emphasizes that despite the mechanism being indirect (via metabolites), the clinical evidence is robust.

The speaker tackles the safety concern head-on. He explains that in vitro (single-cell) studies show HA can accelerate cancer cell growth, which has fueled social media fears. However, when HA supplements were given to mice that already had cancer, there was no difference in tumor growth compared to controls. This suggests that the in vitro effects do not translate to living organisms, likely because the metabolites of HA do not promote cancer in the same way. Furthermore, a 2023 expert panel reviewed all available literature and found no reports of adverse health effects from HA supplements. The speaker concludes that HA supplements are safe, and the cancer scare is not supported by in vivo evidence.

The speaker shares his personal journey: initially, he was convinced by the early evidence that high molecular weight HA was the best form to take. He purchased and used expensive HMW HA supplements. However, after the 2023 study revealed the true absorption mechanism, he realized that the form and molecular weight don't matter for efficacy because everything is broken down into the same metabolites. He then designed his own supplement, 'micro vitamin,' using sodium hyaluronate 200 mg. He chose this form for its enhanced stability, solubility, and smaller molecular size, and the 200 mg dose because it is the most commonly used in clinical trials. He emphasizes that this is his personal choice and not a blanket recommendation for everyone.